Načítá se...
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
PURPOSE: TP53germline (g) mutations, associated with the Li-Fraumeni syndrome (LFS), have rarely been reported in the context of hereditary breast and ovarian cancer (HBOC). The prevalence and cancer risks in this target group are unknown and counseling remains challenging. Notably an extensive high...
Uloženo v:
| Vydáno v: | Arch Gynecol Obstet |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8087555/ https://ncbi.nlm.nih.gov/pubmed/33245408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00404-020-05883-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|